Corsano Health logo
Contact Us
Clinical Evaluation & Procurement Technical Whitepaper

Sepsis Early Detection Wearable Sensor Architecture: How Continuous Multi-Parameter Monitoring Redefines Acute Deterioration Surveillance

A definitive technical guide for global hospital procurement committees, clinical researchers, and MedTech integrators evaluating continuous wrist-worn sensor platforms for early sepsis detection, dynamic EWS scoring, and microvascular shock identification.

CE-MDR Certified FDA 510(k) Cleared ISO 13485 Quality Standard Raw Data Access (Up to 128 Hz) NEWS2 / qSOFA Automated Integration
  • Founded 2019 · Netherlands & Switzerland
  • 10,000+ medical devices produced
  • 35+ hospitals in active clinical use
  • 200+ clinical trials supported
  • Raw PPG/ECG signal access up to 128 Hz
The Clinical & Physiological Challenge

Why Episodic Spot-Checks Fail in Sepsis Detection: The Case for Continuous Sensing

Sepsis claims over 11 million lives annually worldwide. The cornerstone of surviving septic shock is rapid recognition within the "Golden Hour." Traditional general ward monitoring relies on manual spot-checks every 4 to 8 hours, leaving critical systemic inflammatory windows unmonitored.

The Physiology of Sub-Clinical Sepsis Deterioration

Sepsis is a dysregulated host response to infection that leads to life-threatening organ dysfunction. Before overt clinical symptoms manifest—such as severe hypotension, profound hypothermia, or marked altered mental status—the body exhibits micro-physiological alterations that can be captured by continuous wearable telemetry:

  • Microvascular Perfusion Breakdown: Endothelial hyperpermeability and systemic vasodilation cause subtle changes in peripheral pulse wave morphology, measurable via multi-wavelength Photoplethysmography (PPG).
  • Autonomic Nervous System Strain: Early systemic inflammation triggers compensatory sympathetic activation, resulting in subtle resting tachycardia and a severe compression of Heart Rate Variability (HRV) metrics (SDNN, RMSSD, and LF/HF spectral ratios).
  • Thermoregulatory Gradient Shift: Centralization of blood flow produces a widening gradient between core temperature and peripheral skin temperature hours before a spike in central body temperature occurs.
  • Sub-clinical Respiration Rate Spikes: Compensatory tachypnea occurs early as the metabolic acidosis of tissue hypoperfusion sets in, serving as one of the most sensitive individual indicators of impending sepsis deterioration.

When hospitals rely on episodic spot-checks, these physiological micro-trends remain completely invisible. A patient may present normal vital signs at 08:00 AM, begin sub-clinical systemic inflammatory escalation at 10:00 AM, and succumb to septic shock before the next scheduled nursing check at 02:00 PM. Implementing a continuous Sepsis Early Detection Wearable Sensor bridges this lethal observation gap, transforming hospital wards from reactive emergency response units into proactive, data-driven preventative environments.

Corsano continuous sepsis monitoring architecture including CardioWatch 287 wearable sensor, gateway app, and cloud dashboard
Figure 1: Complete Corsano Sepsis Early Detection Infrastructure: Wrist-worn multi-sensor telemetry, secure hub integration, and clinical workstation visualization.
  • Continuous 24/7 Multi-Parameter Telemetry Simultaneous, non-invasive measurement of up to 19 vital parameters derived continuously rather than snapshot spot-checks.
  • Pre-Symptomatic Pattern Recognition Detect subtle changes in pulse wave velocity, peripheral perfusion index, and respiration rate before traditional clinical triggers fire.
  • Automated EWS (NEWS2 / qSOFA) Scores Eliminate manual data entry errors and generate real-time early warning trend lines directly pushed to Electronic Medical Records (EMR).
  • IP-Free Raw Signal Research Access Export unfiltered raw PPG (Green, Red, IR), single-lead ECG, accelerometer, and temperature data up to 128 Hz for proprietary AI model training.
Medical Device Showcase

Corsano CardioWatch 287: The Sepsis Early Detection Wearable Sensor Architecture

Designed specifically for multi-day continuous wear in general wards, post-operative care, and remote post-discharge surveillance, the CardioWatch 287 bracelet combines medical-grade sensor accuracy with superior ergonomic compliance.

Corsano CardioWatch 287-2B Sepsis Early Detection Wearable Sensor
Sensor Hardware

Multi-Spectral Optical & Electrical Sensors

Houses green, red, and infrared optical PPG channels alongside single-lead ECG dry electrodes, high-accuracy skin temperature sensors, and 3-axis accelerometry.

  • Multi-wavelength PPG for microvascular perfusion
  • Continuous thermal flux & skin temperature tracking
  • Single-lead ECG for precise R-R interval extraction
Corsano software integration showing EMR integration and API endpoints
Data Architecture

Bi-Directional EMR & Cloud Integration

Seamlessly routes telemetry data from bedside smart hubs to central nursing dashboards, hospital EMR systems (Epic, Cerner), and analytics engines via REST APIs.

  • HL7 / FHIR compliant data streams
  • Automated patient-to-device pairing
  • Configurable escalation pathways & smart alarms
Unfiltered raw PPG and ECG waveform output at 128 Hz for research
AI & Analytics

Raw Waveform Access (Up to 128 Hz)

Empowers clinical researchers and pharmaceutical partners to extract raw bio-signals, allowing customized digital biomarker engineering for infection response.

  • No black-box vendor lock-in
  • High-resolution waveform telemetry
  • Ideal for training machine learning sepsis models

Complete Parameter Suite for Sepsis Surveillance

The CardioWatch 287 platform continuously measures, computes, and reports up to 19 distinct physiological parameters crucial for early systemic infection detection:

Hemodynamic & Cardiac Metrics

Continuous Heart Rate (HR), Heart Rate Variability (HRV - SDNN, RMSSD, LF/HF), Single-lead ECG Rhythm Strips, Peripheral Perfusion Index (PI), and Pulse Wave Transit Time indices.

Respiratory & Oxygenation Metrics

Continuous Respiration Rate (derived via ECG respiratory sinus arrhythmia and optical PPG pulse wave modulation), SpO2 Trend Monitoring, and Oxygen Saturation Variability.

Thermoregulatory & Metabolic Metrics

Continuous High-Precision Skin Temperature, Peripheral-to-Core Temperature Gradient Tracking, and Galvanic Skin Response (GSR) for stress/autonomic activation monitoring.

Contextual & Behavioral Metrics

3-Axis Accelerometry for Activity Intensity, Posture Analysis (Supine, Prone, Upright), Bed Rest Compliance, and Sleep Architecture Tracking to eliminate motion artifact false positives.

Market Analysis & Forecast

Global healthcare systems, GPOs, and hospital procurement directors are rapidly restructuring their medical wearable procurement criteria. Understanding these macro shifts is critical for clinical decision-makers selecting long-term telemetry infrastructure.

1. Transition from Standalone Gadgets to Certified Medical Ecosystems

Procurement departments are strictly sunsetting "consumer-grade wellness trackers adapted for health use." Regulatory scrutiny under the EU Medical Device Regulation (CE-MDR Class IIa/IIb) and US FDA 510(k) clearances has made certified medical status a mandatory gating requirement. Hospitals now require audited ISO 13485 manufacturing lineage, verifiable software lifecycle management, and clear clinical validation against gold-standard ICU reference monitors.

2. Shift from Single-Parameter Threshold Alarms to Multi-Variate Sensor Fusion

Legacy bedside monitors rely on static threshold alerts (e.g., sound alarm if HR > 100 bpm). This creates severe alarm fatigue, with up to 90% of ward alarms being clinically non-actionable. Future procurement specifies sensor fusion algorithms that cross-analyze trend trajectories—such as elevated respiration rate combined with a drop in peripheral perfusion and a loss of HRV—to calculate dynamic risk indices (e.g., continuous NEWS2) before triggering escalation.

3. The Mandate for Open API and IP-Free Raw Signal Ownership

Hospitals and academic medical centers refuse to be locked into proprietary data silos. Global tenders increasingly mandate open REST APIs, mobile SDKs, and raw signal export capabilities (PPG/ECG waveforms at 128 Hz). Healthcare systems seek ownership of their patient data to feed internal predictive AI engines and participating clinical trial databases without paying recurring data extraction fees.

4. Expansion of the Care Envelope: Hospital-to-Home Sepsis Telemetry

With early post-operative discharge pathways accelerating globally, 30-day readmissions due to surgical site infection and late-onset sepsis represent major financial penalties for health systems. Procurement is shifting toward single-wearable form factors that transition seamlessly from ward admission to post-discharge home monitoring, utilizing the same device, patient interface, and gateway infrastructure.

Innovation Roadmap

Technological Development Trends in Continuous Sepsis Sensing

How next-generation bio-sensors, photoplethysmographic analysis, and edge-AI algorithms are fundamentally redefining the detection window for microvascular and systemic deterioration.

Photoplethysmography (PPG) Waveform Morphology for Vasodilation Tracking

Modern medical wearables do not merely count optical pulses; they evaluate the high-fidelity wave outline of each cardiac contraction. Early septic shock causes systemic vasodilatory tone reduction and microcirculatory shunting. By analyzing morphological features of the PPG signal—such as dicrotic notch position, pulse peak slope, systolic-diastolic area ratios, and peak-to-peak amplitude variability—the Sepsis Early Detection Wearable Sensor detects vascular collapse hours before arterial blood pressure drops.

Automated Risk Scoring: Real-Time Continuous NEWS2 & qSOFA Integration

The National Early Warning Score 2 (NEWS2) and quick Sequential Organ Failure Assessment (qSOFA) are standard manual bedside risk stratification tools. By feeding continuous, noise-filtered physiological parameters into cloud and edge algorithms, the CardioWatch platform generates continuous, automated EWS trajectories:

  • Continuous Respiration Rate (RR): Automatically calculated via multi-modal sensor fusion (ECG-derived respiration + optical PPG pulse envelope modulation), avoiding manual 30-second observation count errors.
  • Continuous Heart Rate (HR): Tracked continuously to detect subtle baseline drifts (+5 to +10 bpm over 2 hours) indicative of compensatory circulatory stress.
  • Continuous Temperature Dynamics: Continuous wrist temperature sensing identifies micro-climatic shivering or peripheral cooling caused by vasoconstrictive compensation.

Edge AI & Low-Power On-Chip Signal Processing

To maximize battery endurance for continuous week-long hospital stays without requiring recharges, modern wearable sensors incorporate edge processing algorithms. Raw sensor noise filtering, artifact rejection (filtering out patient movement during walking or eating), and optical signal quality indexing (SQI) are executed on-device, ensuring only clinically validated, pristine bio-data is transmitted across hospital Wi-Fi or Bluetooth networks.

Enterprise Trust & Evidence

Why Global Health Leaders & MedTech Pioneers Partner with Corsano Health

Corsano Health stands as an audited leader in certified medical wearables. Our platform is backed by comprehensive clinical evidence, global distribution partnerships, and rigorous regulatory compliance.

0Data PointsContinuous physiological signals processed
0Devices ManufacturedUnder ISO 13485 quality control
0Hospitals DeployedAcute general wards and home care
0Clinical TrialsInfection, oncology, cardiovascular
0Vital ParametersDerived from one wrist sensor
0Raw Signal SamplingUnfiltered PPG & ECG export
Regulatory & Quality Approvals

Rigorous Compliance for Hospital-Wide Deployment

Corsano Health does not compromise on regulatory rigor. The CardioWatch 287 platform is engineered and audited under stringent international medical standards:

  • CE-MDR Certification: Audited and issued under the European Medical Device Regulation by notified body Kiwa.
  • FDA 510(k) Clearance: Cleared for clinical monitoring applications in the United States market.
  • ISO 13485: Full quality management system certification covering device design, firmware, manufacturing, and post-market surveillance.
  • Data Privacy & Security: Fully compliant with European GDPR, US HIPAA, and hospital cybersecurity integration frameworks.
Kiwa notified body medical device certification mark for Corsano CardioWatch

Global Strategic Partnerships & Hospital Integrations

Corsano’s medical wearable telemetry is validated and distributed through strategic collaborations with premier global medical technology companies and world-renowned research centers:

Medtronic US distribution partnership announcement
Strategic Alliance

Medtronic Strategic Distribution

Medtronic distributes Corsano multi-parameter wearable solutions in key acute care and monitoring markets across the United States and Europe.

Netcare hospital rollout in South Africa
Hospital Deployment

Netcare Hospital Group Rollout

Continuous wearable ward monitoring deployed across general wards within the Netcare private hospital network in South Africa.

Academic clinical research collaboration
Academic Research

European Consortium Research

Collaborative clinical research initiatives with Radboud UMC, Erasmus MC, Amsterdam UMC, Charité Berlin, and University of Gothenburg.

Technical Procurement FAQ

Frequently Asked Questions for Sepsis Sensor Buyers & Integrators

Addressing key technical, algorithmic, regulatory, and integration queries raised by hospital CTOs, clinical directors, and AI research teams.

The CardioWatch 287 platform combines continuous multi-wavelength Photoplethysmography (PPG), single-lead ECG, skin temperature, and accelerometry to track subtle bio-trends long before threshold alarms fire. Specifically, systemic inflammatory responses trigger autonomic strain (causing Heart Rate Variability compression and subtle baseline HR escalation), microvascular endothelial changes (visible via optical pulse wave amplitude and perfusion index drops), and respiratory compensation (detected via continuous PPG/ECG respiratory derivation). By analyzing the compound trajectory of these metrics, the system identifies sub-clinical sepsis deterioration hours before overt clinical shock.

Yes. Corsano Health is a fully regulated medical device manufacturer. The CardioWatch 287 platform is CE-MDR certified under European Medical Device Regulation and FDA 510(k) cleared in the United States. All hardware, firmware, and cloud software are developed and maintained under an ISO 13485 certified quality management system.

Absolutely. Unlike consumer smartwatches or closed proprietary medical systems, Corsano provides IP-free access to raw, unfiltered bio-signals—including green, red, and infrared PPG optical channels, single-lead ECG, 3-axis accelerometer data, and raw temperature/GSR streams—sampled at up to 128 Hz. Research teams and pharmaceutical developers can utilize our research portal and SDKs to extract raw data without algorithm lock-in.

The Corsano architecture features documented REST APIs, WebSockets, and HL7 / FHIR data export capabilities. Continuous vital sign streams and automated EWS calculations flow securely from bedside smart gateways into central nursing stations, hospital EMR systems, or custom clinical dashboards without altering established clinical documentation workflows.

Motion artifacts are a primary cause of false alarms in wearable monitoring. CardioWatch 287 incorporates an integrated 3-axis accelerometer paired with real-time Signal Quality Index (SQI) algorithms. When a patient is actively walking, eating, or moving, the system flags the signal quality and filters out transient motion noise, ensuring that alerts are generated only from high-fidelity resting bio-data.

The CardioWatch 287 is engineered for continuous multi-day wear on a single charge under standard telemetry configurations. For extended hospital stays, the device utilizes a quick-charging magnetic dock, allowing bedside nursing staff to top up the battery during routine patient hygiene windows without disrupting continuous monitoring continuity.

Yes. A key advantage of the Corsano system is its unified care trajectory. Patients discharged following major surgery or intensive sepsis management can wear the exact same CardioWatch bracelet home. Data syncs automatically via a cellular gateway or mobile app to the outpatient hospital dashboard, alerting care managers to late-onset surgical site infections or secondary sepsis flare-ups.

The system continuously samples Heart Rate, Respiration Rate, SpO2, and Skin Temperature, mapping these parameters directly to the standardized NEWS2 point matrix. Unlike manual nursing entries performed hours apart, the platform updates the composite NEWS2 score continuously, providing a dynamic trend line that highlights rapid patient deterioration trajectories.

The CardioWatch 287 features a fully sealed, IP67/IP68 water- and dust-resistant enclosure made of biocompatible medical-grade polymers. It can be thoroughly disinfected between patient uses using standard hospital-grade disinfectant wipes (e.g., isopropyl alcohol, quaternary ammonium compounds) in compliance with hospital infection prevention policies.

Standard evaluation kits for hospital ward pilots and clinical trial validation can be dispatched within 2 to 4 weeks following contract confirmation. Corsano Health provides complete onboarding support, including technical API integration, clinical nursing staff training, data protection documentation, and custom trial protocol setup.

Request Clinical Specifications & Pilot Evaluation Kit

Speak directly with our medical engineering team, review full regulatory documentation, explore raw signal access SDKs, or initiate a hospital ward pilot for sepsis early detection.

Inquire Now

Disclaimer: Feature availability, specific regulatory indications, and clinical claims may vary by country or region subject to applicable local regulatory approvals, clearances, and medical device classification guidelines.